| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Rosenbaum Marc Wade | Chief Accounting Officer | C/O IRHYTHM HOLDINGS, INC., 699 8TH STREET, #600, SAN FRANCISCO | Marc Rosenbaum | 25 Feb 2026 | 0001929535 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IRTC | Common Stock | Sale | $39,455 | -280 | -2.6% | $140.91 | 10,601 | 24 Feb 2026 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 12, 2025 and modified on November 25, 2025. |
On January 12, 2026, iRhythm Technologies, Inc. (iRhythm Tech) and iRhythm Holdings, Inc. (Issuer) effectuated a holding company reorganization pursuant to which the Issuer became the successor issuer to iRhythm Tech pursuant to Rule 12g-3(a) of the Securities Exchange Act of 1934, as amended. On such date, all outstanding shares and equity awards of iRhythm Tech automatically converted into securities of the Issuer on a one for one basis, with no change to the proportionate interests of security holders.